NCT02899663

Brief Summary

Systematic retrospective medical chart and medical imaging file review of all patients receiving brain MRI for the follow-up of glioblastoma.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

September 9, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 14, 2016

Completed
Last Updated

September 14, 2016

Status Verified

September 1, 2016

Enrollment Period

7 months

First QC Date

September 9, 2016

Last Update Submit

September 13, 2016

Conditions

Glioblastoma

Outcome Measures

Primary Outcomes (1)

  • Number of microbleeds diagnosed with MRI (susceptibility weighted imaging sequence)

    At the time of each MRI conducted within 5 years after diagnosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients suffering from brain glioblastoma

You may qualify if:

  • Adult patients
  • Diagnosed with brain glioblastoma
  • Receiving treatment with cranial radiotherapy and/or chemotherapy
  • Having at least one follow-up MRI conducted that used a susceptibility weighted imaging sequence

You may not qualify if:

  • Underage
  • Absence of formal diagnosis of glioblastoma
  • No available medical imaging file with MRI susceptibility weighted imaging sequence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Glioblastoma

Condition Hierarchy (Ancestors)

AstrocytomaGliomaNeoplasms, NeuroepithelialNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Glandular and EpithelialNeoplasms, Nerve Tissue

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2016

First Posted

September 14, 2016

Study Start

January 1, 2015

Primary Completion

August 1, 2015

Last Updated

September 14, 2016

Record last verified: 2016-09